Should I Buy VRSN? VRSN 2026 Analysis

Should You Buy VeriSign, Inc (VRSN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

224.170

1 Day change

-7.60%

52 Week Range

310.600

Analysis Updated At

2026/01/30

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer. VRSN is sitting right on support (~244) with weakening momentum (bearish MACD expansion) and heavy insider selling, while Intellectia signals show no edge today. The setup looks more like a “wait for confirmation or a cleaner dip” than an immediate-entry buy; I would hold/avoid initiating a new position until it reclaims the 249–254 area or shows a clear reversal off support.

Intellectia Proprietary Trading Signals

AI Stock Picker: No signal on given stock today.
SwingMax: No signal on given stock today.

Technical Analysis

Trend/momentum is leaning bearish-to-neutral in the near term.

Price vs levels: Close ~245.5 is below the pivot (249.206) and essentially sitting on S1 support (244.156). A decisive break below S1 opens room toward S2 (241.036).
MACD: Histogram -0.369 and negatively expanding = downside momentum is building, not fading yet.
RSI(6): 34.7 (near oversold-ish but still “neutral” per provided interpretation). This can support a short bounce, but it’s not a confirmed reversal signal.
Moving averages: Converging MAs suggest a transition zone; without a reclaim of pivot/resistance, the bias remains cautious.
Probabilistic pattern read: modest upside odds near-term (next day/week), but this is consistent with a support-area bounce attempt rather than a strong trend entry. Key levels to watch: Resistance 249.2 (pivot), then 254.3; Support 244.2 then 241.0.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment from options is mildly bullish (puts < calls on both OI and volume), suggesting traders are not aggressively hedging downside.

Put/Call (OI) 0.68 and Put/Call (Volume) 0.74 = call-leaning positioning.
Implied vol: 30D IV ~28.68 with IV percentile 86 (elevated vs its own history). This often happens into event risk (earnings on 2026-02-05) and implies the market is pricing a larger move than usual.
Volume context: Today’s options volume is low vs recent averages (provided 5D/10D averages are higher), so the bullish skew isn’t backed by unusually strong fresh flow.

Technical Summary

Sell

Buy

Positive Catalysts

Earnings catalyst ahead: QDEC 2025 earnings on 2026-02-05 (after hours). A beat/raise could help it reclaim the 249–254 resistance zone.
Underlying business trends: Analyst commentary cites incrementally stronger .com trends (domain base +3% YoY), supportive for steady cash-flow narrative.
Solid recent operating performance: Latest reported quarter (2025/Q
showed continued revenue/EPS growth, helping downside be more “supportable” fundamentally.

Neutral/Negative Catalysts

Insider selling: Insiders are selling, with selling amount up ~885% over the last month (clear negative signal vs near-term upside conviction).
Technical momentum: Bearish MACD expansion while price sits below pivot increases risk of a support break (244 -> 241).
Macro/event overhang: Market cautious around jobs data and government funding/shutdown risk; these can pressure multiples and risk appetite even for defensive names.
Elevated IV into earnings: The market is pricing a bigger move; if earnings are merely “fine,” the stock can still drift or drop (disappointment risk).

Financial Performance

Latest quarter provided: 2025/Q3.

Revenue: $419.1M, +7.30% YoY (steady growth).
Net income: $212.8M, +5.71% YoY.
EPS: $2.27, +9.66% YoY (EPS growing faster than revenue).
Gross margin: 88.36% (slightly up YoY), reinforcing a high-margin, resilient business model. Overall: fundamentals are solid and consistent, but they are not currently overpowering the near-term technical/insider-sentiment headwinds.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: limited change; the latest update (2026-01-06) is a small price target increase to $271 from $270 with a Neutral rating (JPMorgan). That implies modest upside (~10% from ~245) but signals Wall Street views shares as fairly valued rather than a high-conviction buy. Wall Street pros: stable/defensive business model, improving .com trends, consistent growth and very high margins. Wall Street cons: valuation perceived as fair, not many near-term catalysts besides earnings, and sentiment is dampened by significant insider selling. Politicians/congress: No recent congress trading data available (no notable political activity indicated).

3 Analyst Rating

Wall Street analysts forecast VRSN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VRSN is 311 USD with a low forecast of 271 USD and a high forecast of 337 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 242.620

Low

271

Averages

311

High

337

Current: 242.620

Low

271

Averages

311

High

337

JPMorgan

Alexei Gogolev

Neutral

maintain

$270 -> $271

AI Analysis

2026-01-06

Reason

JPMorgan

Alexei Gogolev

Price Target

$270 -> $271

AI Analysis

2026-01-06

maintain

Neutral

Reason

JPMorgan analyst Alexei Gogolev raised the firm's price target on VeriSign to $271 from $270 and keeps a Neutral rating on the shares. The .com domain base recorded 161M total domains as of December 31, up 3% year-over-year, according to Verisign data, the analyst tells investors in a research note. The firm is "encouraged" by the incrementally stronger trends in .com and reflected that in its model. However, the firm still views VeriSign shares as fairly valued.

JPMorgan

Alexei Gogolev

Neutral

initiated

$270

2025-10-28

Reason

JPMorgan

Alexei Gogolev

Price Target

$270

2025-10-28

initiated

Neutral

Reason

JPMorgan analyst Alexei Gogolev initiated coverage of VeriSign with a Neutral rating and $270 price target. The firm says the company's "resilient" business model and "robust" profitability is balanced against a "moderate" growth trajectory and ongoing competitive pressures. It sees limited near-term catalysts for the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for VRSN

Unlock Now

VRSN Should I Buy

VRSN Should I Buy

Should You Buy VeriSign, Inc (VRSN) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch